Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BINAP. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
Patent CN100463720C introduces a novel binaphthyl axis-containing chiral catalyst enabling high-yield asymmetric synthesis with enhanced supply chain reliability and significant cost reduction potential for pharma intermediates.
Patent CN118878452B enables high-yield synthesis under mild conditions with significant cost savings for reliable pharmaceutical intermediate supply chains.
Patent CN120247882B introduces a mild one-step synthesis method for nitrogen heterocycle-derived polyarylmethane antitumor compounds with high MCF-7 cytotoxicity enabling significant cost reduction and scalable pharmaceutical manufacturing.
Patent CN120247882B enables mild organocatalytic production of cytotoxic compounds against MCF-7 cells with scalable manufacturing advantages.
Patent CN102276376B introduces an efficient synthesis route eliminating chiral resolution, enhancing purity and reducing supply chain costs for pharmaceutical intermediates.
Solve chiral synthesis challenges with metal-free helicene production. 99% ee, 68% yield. Reduce costs & supply risks for asymmetric catalysis.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Solve supply chain risks in acetaminoacrylate production with green binaphthol phosphate catalysis. 85%+ yields under mild conditions. Contact for CDMO solutions.
Discover how this dual-chiral ligand enables 91% ee in asymmetric reactions, reducing R&D costs and supply chain risks for pharmaceutical intermediates.